Evoke Pharma Stock Analysis

Evoke Stock Analysis Notes

About 17.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.58. Some equities with similar Price to Book (P/B) outperform the market in the long run. Evoke Pharma recorded a loss per share of 10.13. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 1st of August 2024. Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Evoke Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. To learn more about Evoke Pharma call David RPh at 858 345 1494 or check out https://www.evokepharma.com.

Evoke Pharma Investment Alerts

Evoke Pharma Upcoming and Recent Events

Evoke Largest EPS Surprises

View All Earnings Estimates

Evoke Pharma Environmental, Social, and Governance (ESG) Scores

Evoke Stock Institutional Investors

Note, although Evoke Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Evoke Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.91 M.

Evoke Profitablity

The company has Profit Margin (PM) of (0.71) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.48) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.48.

Management Efficiency

Evoke Pharma has return on total asset (ROA) of (0.335) % which means that it has lost $0.335 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4991) %, meaning that it created substantial loss on money invested by shareholders. Evoke Pharma's management efficiency ratios could be used to measure how well Evoke Pharma manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Evoke Pharma's Return On Capital Employed is quite stable compared to the past year. Return On Equity is expected to rise to 2.85 this year, although the value of Return On Tangible Assets will most likely fall to (1.04). At this time, Evoke Pharma's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 10.1 M this year, although the value of Non Current Liabilities Total will most likely fall to about 4.8 M.

Technical Drivers

As of the 31st of January, Evoke Pharma shows the Downside Deviation of 4.75, coefficient of variation of 140822.21, and Mean Deviation of 3.91. Evoke Pharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Evoke Pharma Price Movement Analysis

Evoke Pharma Insider Trading Activities

Evoke Pharma Outstanding Bonds

Evoke Pharma Predictive Daily Indicators

Evoke Pharma Corporate Filings

Evoke Pharma Forecast Models

Evoke Pharma's time-series forecasting models are one of many Evoke Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Evoke Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Evoke Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Evoke shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Evoke Pharma. By using and applying Evoke Stock analysis, traders can create a robust methodology for identifying Evoke entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Evoke analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Evoke analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Evoke Pharma stock analysis indicators help investors evaluate how Evoke Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Evoke Pharma shares will generate the highest return on investment. By understating and applying Evoke Pharma stock analysis, traders can identify Evoke Pharma position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.